Orchestra BioMed Holdings Inc (NASDAQ: OBIO) Stock Dropped -7.56% Over A Month – Are There Any Chances Of Growth?

During the last session, Orchestra BioMed Holdings Inc (NASDAQ:OBIO)’s traded shares were 1.72 million, with the beta value of the company hitting 0.52. At the end of the trading day, the stock’s price was $5.38, reflecting an intraday gain of 34.50% or $1.38. The 52-week high for the OBIO share is $10.06, that puts it down -86.99 from that peak though still a striking 26.39% gain since the share price plummeted to a 52-week low of $3.96. The company’s market capitalization is $204.51M, and the average intraday trading volume over the past 10 days was 90840.0 shares, and the average trade volume was 58.80K shares over the past three months.

Orchestra BioMed Holdings Inc (NASDAQ:OBIO) trade information

Orchestra BioMed Holdings Inc (OBIO) registered a 34.50% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 34.50% in intraday trading to $5.38, hitting a weekly high. The stock’s 5-day price performance is 14.47%, and it has moved by -7.56% in 30 days. Based on these gigs, the overall price performance for the year is -38.72%. The short interest in Orchestra BioMed Holdings Inc (NASDAQ:OBIO) is 0.7 million shares and it means that shorts have 12.57 day(s) to cover.

Orchestra BioMed Holdings Inc (OBIO) estimates and forecasts

Statistics show that Orchestra BioMed Holdings Inc has underperformed its competitors in share price, compared to the industry in which it operates. Orchestra BioMed Holdings Inc (OBIO) shares have gone down -28.93% during the last six months, with a year-to-date growth rate less than the industry average at -12.16% against 16.70.

While earnings are projected to return -12.09% in 2025.

OBIO Dividends

Orchestra BioMed Holdings Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Orchestra BioMed Holdings Inc (NASDAQ:OBIO)’s Major holders

Orchestra BioMed Holdings Inc insiders own 21.99% of total outstanding shares while institutional holders control 54.96%, with the float percentage being 70.45%.